GRP
RAPP

Global Retirement Partners’s Rapport Therapeutics RAPP Stock Holding History

Global Retirement Partners’s Portfolio RAPP Stock Details RAPP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.21K Sell
40
-5
-11% -$138 ﹤0.01% 3849
2025
Q3 		$1.34K Buy
+45
New +$803 ﹤0.01% 3448

Other funds holding RAPP

TGV
TRV GP V Boston, Massachusetts $401M AUM 284.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Global Retirement Partners's RAPP Position: Q4 2025 in Review

Global Retirement Partners reduced its Rapport Therapeutics (RAPP) stake by 11% in Q4 2025, selling an estimated $138 and leaving 40 shares worth $1.21K. The position accounts for ﹤0.01% of the portfolio, ranked #3849.

Global Retirement Partners first reported a position in RAPP in Q3 2025 and has held it in 2 quarters since. The position peaked at $1.34K in Q3 2025. 144 funds tracked by Wall St. Rank hold RAPP as of Q4 2025.

  • Global Retirement Partners held 40 shares of Rapport Therapeutics worth $1.21K as of Q4 2025.
  • Global Retirement Partners sold 5 Rapport Therapeutics shares in Q4 2025, an estimated $138.
  • Rapport Therapeutics made up ﹤0.01% of Global Retirement Partners's portfolio in Q4 2025, its #3849 holding.
  • Global Retirement Partners first reported a position in Rapport Therapeutics in Q3 2025 and has held it in 2 quarters since.
  • Global Retirement Partners's Rapport Therapeutics position peaked at $1.34K in Q3 2025.
  • 144 funds tracked by Wall St. Rank held Rapport Therapeutics as of Q4 2025.

Based on Global Retirement Partners's 13F filing for Q4 2025, filed 6 Feb 2026.